Cancer Clinical Research in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Cancer Clinical Research in Colombia

Cancer Clinical Research in Colombia – Cohortias the CRO of LATAM

Cancer remains a pressing global health concern, impacting millions of lives worldwide. Clinical research serves as the cornerstone of progress in understanding and treating cancer, offering hope for improved therapies and enhanced patient outcomes.

In Colombia, a country with a growing healthcare landscape and diverse population, cancer clinical research is making notable strides. This blog explores the advancements, challenges, and potential prospects of cancer clinical research in Colombia.

Advancements in Cancer Clinical Research

Colombia’s commitment to cancer clinical research is evident through the collaborative efforts of healthcare institutions, academic centers, and governmental bodies. Over the years, significant advancements have been achieved:

  1. Research Collaborations: Colombian researchers and institutions are increasingly collaborating with international counterparts in conducting multicenter clinical trials. This collaboration not only facilitates the exchange of knowledge but also allows Colombian patients to access cutting-edge treatments.
  2. Innovative Therapies: Clinical trials in Colombia have contributed to the development and testing of innovative cancer therapies. These trials focus on various aspects of cancer treatment, including targeted therapies, immunotherapy, and novel drug combinations.
  3. Patient Diversity: Colombia’s diverse population provides a unique opportunity to study the genetic and ethnic factors that influence cancer development and treatment responses. This diversity contributes valuable insights to global oncology research.
  4. Government Support: The Colombian government has demonstrated support for cancer research by providing funding and creating a conducive environment for clinical trials. Regulatory frameworks have been established to ensure patient safety and ethical standards.

Challenges in Cancer Clinical Research

While Colombia has made remarkable progress, there are challenges that need to be addressed to maximize the impact of cancer clinical research:

  1. Awareness and Education: Lack of awareness about the importance of clinical trials among both patients and healthcare providers can hinder participation. Efforts are needed to educate the public and healthcare professionals about the benefits of research participation.
  2. Access to Trials: Ensuring equitable access to clinical trials across different regions and socioeconomic backgrounds is crucial. Disparities in healthcare access can affect patient recruitment and representation.
  3. Research Infrastructure: Strengthening research infrastructure, including clinical trial facilities and research expertise, is essential for conducting high-quality trials that meet international standards.
  4. Data Sharing: Encouraging data sharing and collaboration among researchers can accelerate discoveries. Establishing platforms for data exchange can facilitate the pooling of resources and knowledge.
  5. Patient-Centric Approach: Focusing on patient well-being and understanding their concerns during clinical trials is vital. Implementing patient-centric practices can enhance recruitment, retention, and overall trial success.

Cancer Clinical Research in Colombia

Cancer Clinical Research in Colombia

Cancer Clinical Research in Colombia

Promising Prospects and Future Directions

Colombia holds substantial potential in cancer clinical research, offering several avenues for growth:

  1. Biomarker Research: Leveraging Colombia’s genetic diversity can lead to discoveries in cancer biomarkers, enabling more targeted and personalized treatments for patients of various ethnic backgrounds.
  2. Early Detection Strategies: Research aimed at identifying early detection methods tailored to the Colombian population’s genetic makeup and lifestyle factors can significantly impact cancer survival rates.
  3. Collaborative Networks: Strengthening collaborations between Colombian institutions and global research networks can enhance the country’s contribution to cutting-edge oncology research.
  4. Training and Capacity Building: Investing in training programs for healthcare professionals and researchers can further elevate the quality of cancer clinical research in Colombia.
  5. Patient Engagement: Engaging patients and involving them in research design and implementation can lead to more patient-centered trials and better outcomes.


Cancer clinical research in Colombia has come a long way, reflecting the nation’s commitment to advancing cancer care through innovation and collaboration. While challenges persist, Colombia’s potential to make substantial contributions to global oncology research remains undeniable.

By addressing awareness gaps, ensuring equitable access, and fostering a patient-centric approach, Colombia can continue to build on its achievements and enhance the landscape of cancer clinical research.

With ongoing dedication from healthcare professionals, researchers, policymakers, and the public, Colombia’s impact on cancer treatment and patient outcomes will undoubtedly grow, benefiting both its population and the broader global community.

Cancer Clinical Research in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Cancer Clinical Research in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Cancer Clinical Research in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Cancer Clinical Research in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Cancer Clinical Research in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Cancer Clinical Research in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Cancer Clinical Research in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Cancer Clinical Research in Colombia

The Cohortias Team

Cancer Clinical Research in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Cancer Clinical Research in Colombia

Network & Partnerships